- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Astellas Pharma China, Inc.
Total 1222 results
-
Astellas Pharma IncAstellas Pharma US, Inc.; Advanz PharmaCompletedAtrial Fibrillation | Atrial FlutterPoland, United States, Canada, Argentina, Denmark, India
-
Astellas Pharma s.r.o.CompletedPost-operative Peripheral Neuropathic PainCzech Republic
-
Astellas Pharma Global Development, Inc.Not yet recruiting
-
Astellas Pharma Global Development, Inc.Recruiting
-
Astellas Pharma Global Development, Inc.CompletedChronic Kidney DiseaseGermany
-
Astellas Pharma Global Development, Inc.Active, not recruiting
-
Astellas Pharma Global Development, Inc.Active, not recruiting
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingAllergic to House Dust MitesGermany
-
Astellas Pharma Global Development, Inc.CompletedVasomotor SymptomsPoland, Spain, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Sweden, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedChronic Tympanic Membrane PerforationUnited States
-
Astellas Pharma Global Development, Inc.TerminatedPharmacokinetics of Mirabegron | Overactive Bladder (OAB)Korea, Republic of, Russian Federation, Turkey
-
Astellas Pharma Global Development, Inc.CompletedOvarian Cancer | NSCLC | Solid Tumors | ESCCUnited States
-
Astellas Pharma Global Development, Inc.CompletedRenal Impaired | Gilteritinib | Normal Renal Function | Pharmacokinetics of ASP2215United States, Bulgaria
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.TerminatedHealthy ParticipantsUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Metastatic Hormone-sensitive Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Withdrawn
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia | Advanced Solid TumorsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedHealthy SubjectsUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-labeled GilteritinibUnited States
-
Astellas Pharma Global Development, Inc.Terminated
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma Global Development, Inc.WithdrawnSolid Tumors | Epidermal Growth Factor Receptor (EGFR) Mutations
-
Astellas Pharma Global Development, Inc.CompletedCoronary Artery Disease (CAD)United States, Peru, Argentina, Puerto Rico
-
Astellas Pharma Global Development, Inc.TerminatedCandidiasisPhilippines, United States, Canada, Israel, Romania, Greece, Turkey, Brazil, Bulgaria, Colombia, Hungary, Ukraine
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP015K | Food EffectUnited States
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis | Pharmacokinetics of ASP2409United States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Subjects | Pharmacokinetics of ASP2408United States
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis | Pharmacokinetics of ASP2408United States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Korea, Inc.Seagen Inc.RecruitingUrothelial CancerKorea, Republic of
-
Astellas Pharma IncActive, not recruitingPrimary Mitochondrial MyopathyUnited States
-
Astellas Pharma IncCompletedGastric Cancer | Gastro-esophageal Junction (GEJ) CancerJapan
-
Astellas Pharma IncTerminatedDuchenne Muscular Dystrophy (DMD)United States
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAdvanced Solid TumorsJapan
-
Astellas Pharma IncCompletedArthritis, RheumatoidJapan, Korea, Republic of, Taiwan
-
Astellas Pharma IncCompletedInterstitial Pneumonia Associated With Polymyositis/DermatomyositisJapan
-
Astellas Pharma IncCompletedIrritable Bowel Syndrome With Constipation (IBS-C)Japan
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
Astellas Pharma IncCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Astellas Pharma IncCompletedRheumatoid Arthritis (RA)Japan
-
Astellas Pharma IncCompleted